Are Covid-19 vaccines safe for cancer patients? Here is what cancer experts say kvia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kvia.com Daily Mail and Mail on Sunday newspapers.
Dr. Fauci assures that there are no red flags for pregnant women receiving COVID vaccines and says 10,000 have safely got shots so far
Dr Fauci said there have been no red flags as Moderna, Pfizer and the FDA have followed up with women who became pregnant in vaccine trials
Women were barred from COVID-19 vaccine trials, as is typical in shot studies, so there is little known about the effects
Dr Fauci said more than 10,000 women have had at least one dose of the shot
Pregnant women who catch coronavirus are at higher risk of stillbirth than other women and are 13 times more likely to die of the infection than others
Fighting Racial Inequity by Funding Black Scientists
Representatives from a network of women deans, chairs and distinguished faculty in biomedical engineering are calling upon the National Institutes of Health and other funding agencies to address disparities in allocating support to Black researchers. The group made the call to action in the Jan. 26, 2021, issue of the journal Cell.
In examining the racial inequities and injustices that prevent Black faculty from equitably contributing to science and achieving their full potential, insufficient federal funding for research by Black scientists rose to the top as a key issue.
According to studies of National Institutes of Health research funding allocations, Black applicant award rates have stood at about 55 percent of that of white principal investigators of similar academic achievement. Despite internal reviews of the reasons behind this disparity, and promises to do better, the funding gap continues.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
February 02, 2021 14:21 ET | Source: Medexus Pharmaceuticals Inc Medexus Pharmaceuticals Inc
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“
Medexus”) (TSXV: MDP) (OTCQX: MEDXF)
(Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class .
Medexus Pharmaceuticals IncFebruary 2, 2021 GMT
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“Medexus Pharma” and together with Medexus, the “Company”) entered into a Commercialization and Supply Agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. (“medac”), pursuant to which medac has granted Medexus Pharma an excl